5 articles
Universal pan-vascular interventional robot by Aopeng Medical featuring AI-powered navigation, force feedback, and 0.1mm precision for coronary, peripheral, and neurovascular procedures.
›Coronary intravascular lithotripsy (IVL) system for treating calcified coronary artery lesions, NMPA approved October 2023; described by the manufacturer as China's first domestically developed coronary IVL platform.
›Coronary PCI surgical robot with biomimetic dual-hand control, first commercially available interventional cardiology robot in China.
›Shenzhen-based medical device company developing intravascular lithotripsy systems and ultrasound imaging solutions for pan-vascular disease treatment.
›WeMed Medical's ETcath received NMPA approval March 21, 2025, becoming China's first fully domestically developed robot for percutaneous coronary intervention.
›